ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,250.50
0.60%
S&P ASX All Technology
3,828.50
0.37%
Brent Oil
76.495
0.00%
US Dollar vs AUD
1.60849
0.00%
Bitcoin
98,247.82
0.04%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. aTyr Pharma Inc (ATYR)

  7. aTyr Pharma Inc (ATYR) News

ATYR

aTyr Pharma (ATYR)

aTyr Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATYR
DateTimeSourceHeadlineSymbolCompany
24/12/202408:48Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ATYRaTyr Pharma Inc
24/12/202408:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATYRaTyr Pharma Inc
18/12/202400:00GlobeNewswire Inc.aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ATYRaTyr Pharma Inc
13/12/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATYRaTyr Pharma Inc
13/12/202408:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATYRaTyr Pharma Inc
13/12/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATYRaTyr Pharma Inc
13/12/202408:00GlobeNewswire Inc.aTyr Pharma Announces the Appointment of Eric Benevich to its Board of DirectorsNASDAQ:ATYRaTyr Pharma Inc
11/12/202400:00GlobeNewswire Inc.aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary SarcoidosisNASDAQ:ATYRaTyr Pharma Inc
10/12/202400:00GlobeNewswire Inc.aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on FibrosisNASDAQ:ATYRaTyr Pharma Inc
16/11/202400:00GlobeNewswire Inc.aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on FibrosisNASDAQ:ATYRaTyr Pharma Inc
15/11/202410:51Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ATYRaTyr Pharma Inc
08/11/202408:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATYRaTyr Pharma Inc
08/11/202408:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATYRaTyr Pharma Inc
08/11/202408:01GlobeNewswire Inc.aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate UpdateNASDAQ:ATYRaTyr Pharma Inc
31/10/202423:00GlobeNewswire Inc.aTyr Pharma to Present at Upcoming Investor ConferencesNASDAQ:ATYRaTyr Pharma Inc
16/10/202408:01Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ATYRaTyr Pharma Inc
08/10/202423:00GlobeNewswire Inc.aTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual MeetingNASDAQ:ATYRaTyr Pharma Inc
02/10/202422:00GlobeNewswire Inc.aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory JournalNASDAQ:ATYRaTyr Pharma Inc
21/08/202422:00GlobeNewswire Inc.aTyr Pharma to Participate in September Investor ConferencesNASDAQ:ATYRaTyr Pharma Inc
14/08/202406:00GlobeNewswire Inc.aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update NASDAQ:ATYRaTyr Pharma Inc
06/08/202422:00GlobeNewswire Inc.aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical OperationsNASDAQ:ATYRaTyr Pharma Inc
30/07/202422:00GlobeNewswire Inc.aTyr Pharma Announces Research Study with Stanford MedicineNASDAQ:ATYRaTyr Pharma Inc
22/07/202422:00GlobeNewswire Inc.aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary SarcoidosisNASDAQ:ATYRaTyr Pharma Inc
03/06/202422:00GlobeNewswire Inc.aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”NASDAQ:ATYRaTyr Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:ATYR

Your Recent History

NYSE
MRK
Merck
NYSE
KO
Coca Cola
FX
GBPAUD
Sterling vs AUD
NYSE
XOM
Exxon Mobil
ASX
TLS
Telstra
ASX
XMM
S&P ASX 300 Metals and M...
ASX
XFL
S&P ASX 50
ASX
CSL
CSL
ASX
WDC
Westfield
ASX
XJO
S&P ASX 200
COIN
ADAUSD
Cardano
COIN
SOLUSD
Solana
ASX
ANZ
Australia And New Zealan...
ASX
NCM
Newcrest Mining
ASX
WES
Wesfarmers
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads